CCCC · C4 Therapeutics, Inc.

NasdaqHealthcareBiotechnology

C4 Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Dedicated To Delivering On The Promise Of Targeted Protein Degradation Science To Create A New Generation Of Medicines That Transforms Patient'S Lives. The Company Is Progressing Targeted Oncology Programs Through Clinical Studies And Leveraging Its Torpedo Platform To Efficiently Design And Optimize Small-Molecule Medicines To Address Difficult-To-Treat Diseases. The Degrader Medicines Of The Company Are Designed To Harness The Body'S Natural Protein Recycling System To Rapidly Degrade Disease-Causing Proteins, Offering The Potential To Overcome Drug Resistance, And Drug Undruggable Targets And Improve Patient Outcomes. Its Pipeline Is Cemsidomide, Cft8919, And Other Discovery Products.

HealthcareNasdaqUS

FLOAT

98.5M

FREE FLOAT %

80%

SHARES O/S

123.0M

MARKET CAP

$376.5M

EXCHANGE

Nasdaq

COUNTRY

CCCC Catalyst History

No catalysts recorded for CCCC yet

Day Trader Sniper hasn't classified a publishable catalyst for CCCC yet. New events appear here as they're scored.

Be early on the next CCCC spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

CCCC · C4 Therapeutics, Inc.

CCCC Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.